GlassScriptPhysician profile
William C Aldrich
NPI 1356458061
$8,904.83
in general payments reported to CMS, 2019-2025
54 companies · $806 in 2025
The $806 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,635 · 2020: $1,850 · 2021: $1,793 · 2022: $1,174 · 2023: $635 · 2024: $1,013 · 2025: $806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,394 · Education: $32.27 · Entertainment: $26.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,394.37 |
| Education | $32.27 |
| Entertainment | $26.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,364.62 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $718.34 | 2020-2025 | Vraylar, Viberzi, Linzess |
| Novo Nordisk INC | $595.70 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Insulet Corporation | $358.96 | 2019-2025 | Omnipod |
| Glaxosmithkline, LLC. | $357.37 | 2019-2025 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $347.72 | 2019-2024 | Jardiance, Synjardy |
| Sanofi-Aventis U.S. LLC | $335.53 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $292.74 | 2019-2022 | |
| Lilly USA, LLC | $292.48 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Pfizer INC. | $272.31 | 2019-2025 | |
| Abbott Laboratories | $249.09 | 2021-2024 | Freestyle Libre 3 |
| Amgen INC. | $239.02 | 2019-2025 | Krystexxa |
| Biohaven Pharmaceutical Holding Company LTD. | $238.75 | 2022 | |
| Novartis Pharmaceuticals Corporation | $212.08 | 2019-2024 | |
| Biohaven Pharmaceuticals, INC. | $198.59 | 2020-2021 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $192.78 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $178.35 | 2019-2022 | |
| Astellas Pharma US INC | $170.32 | 2019-2021 | |
| Allergan, INC. | $162.18 | 2019-2020 | |
| Stryker Corporation | $148.92 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Exact Sciences Corporation | $145.79 | 2023-2025 | Cologuard Collection Kit |
| Dexcom, INC. | $138.13 | 2021-2024 | Dexcom G6 Transmitter |
| Supernus Pharmaceuticals, INC. | $130.91 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $119.52 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $119.07 | 2023-2024 | Gemtesa |
| Alnylam Pharmaceuticals INC. | $115.37 | 2020-2021 | |
| Eisai INC. | $95.44 | 2020-2022 | |
| Ironwood Pharmaceuticals, INC | $86.62 | 2020-2021 | |
| Amarin Pharma, INC. | $82.73 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $82.45 | 2021-2022 | |
| Horizon Therapeutics Plc | $80.43 | 2020-2021 | |
| Upsher-Smith Laboratories LLC | $79.62 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $73.46 | 2019-2021 | |
| Corcept Therapeutics | $59.47 | 2022-2025 | Korlym |
| Edwards Lifesciences Corporation | $53.06 | 2021-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Seqirus USA INC | $52.54 | 2021-2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Verity Pharmaceuticals INC. | $42.42 | 2024 | Tlando |
| Mylan Specialty L.P. | $40.81 | 2019-2021 | |
| Xeris Pharmaceuticals, INC. | $39.11 | 2024 | Recorlev |
| Viatris Specialty LLC | $38.64 | 2025 | Yupelri |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $37.88 | 2022-2023 | |
| Intra-Sana Laboratories | $36.54 | 2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Optos, INC. | $26.96 | 2023-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| E.R. Squibb & Sons, L.L.C. | $26.00 | 2021 | |
| Cvrx, INC. | $24.16 | 2024 | Barostim Neo System |
| Ardelyx, INC. | $19.78 | 2024 | Ibsrela |
| Genentech USA, INC. | $19.36 | 2019 | |
| Vanda Pharmaceuticals INC. | $19.36 | 2025 | Fanapt, Hetlioz |
| Tactile Systems Technology INC | $18.92 | 2025 | Nimbl, Flexitouch Plus |
| Shire North American Group INC | $18.10 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $15.38 | 2020 | |
| Sunovion Pharmaceuticals INC. | $15.07 | 2021 | |
| Mannkind Corporation | $13.54 | 2019 | |
| Sanofi Pasteur INC. | $12.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Aldrich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.